D

    Dr. Reddy’s Laboratories Ltd ADR (RDY)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE

    $12.12
    -0.06 (-0.49%)

    Market Cap: $10.15B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    65%(22/34)
    Avg Surprise
    +240.32%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$N/A
    Revenue Consensus
    $84.5B
    Range$83.1B - $86.0B
    5 analysts
    Dec 31, 2026
    EPS Consensus$N/A
    Revenue Consensus
    $89.9B
    Range$88.2B - $93.0B
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-N/A---
    Sep 26EST
    		-N/A---
    Jun 26
    		$0.06N/A-64.71%Miss-99.6%
    Mar 26
    		$0.00N/A-100.00%Miss-100.0%
    Dec 25
    		$0.16$0.16+1.94%Beat-99.0%
    Sep 25
    		$0.20N/A-98.92%Miss-98.8%
    Jun 25
    		$17.02$0.21+8004.76%Beat+1.9%
    Mar 25
    		$19.11$17.13+11.56%Beat+23.0%
    Dec 24
    		$16.94$16.15+4.89%Beat+1.8%
    Sep 24
    		$15.83$17.69-10.51%Miss-11.1%
    Jun 24
    		$16.70$17.12-2.45%Miss-0.9%
    Mar 24
    		$15.54$13.55+14.69%Beat+29.5%
    Dec 23
    		$16.64$13.26+25.49%Beat+12.1%
    Sep 23
    		$17.81$11.60+53.53%Beat+31.9%
    Jun 23
    		$16.85$10.51+60.32%Beat+17.6%
    Mar 23
    		$12.00$10.90+10.09%Beat+17042.9%
    Dec 22
    		$14.84$9.55+55.39%Beat+73.6%
    Sep 22
    		$13.50$9.39+43.77%Beat+12.5%
    Jun 22
    		$14.33$8.37+71.21%Beat+109.2%
    Mar 22
    		$0.07N/A-87.27%Miss-84.8%
    Dec 21
    		$8.55$12.84-33.41%Miss+1055.4%
    Sep 21
    		$12.00$9.54+25.79%Beat+30.4%
    Jun 21
    		$6.85$9.82-30.24%Miss-0.6%
    Mar 21
    		$0.46$0.51-9.80%Miss-24.6%
    Dec 20
    		$0.74N/A-90.41%Miss-91.8%
    Sep 20
    		$9.20$7.19+27.96%Beat-29.9%
    Jun 20
    		$6.89$7.85-12.23%Miss-13.7%
    Mar 20
    		$0.61$0.49+24.49%Beat+63.8%
    Dec 19
    		$9.05$7.20+25.69%Beat+2123.0%
    Sep 19
    		$13.12$7.01+87.16%Beat+3076.0%
    Jun 19
    		$7.98$5.14+55.25%Beat+1896.5%
    Mar 19
    		$0.37$0.33+12.88%Beat+39.5%
    Dec 18
    		$0.41$0.32+27.22%Beat-98.4%
    Sep 18
    		$0.41$0.30+37.70%Beat-97.6%
    Jun 18
    		$0.40$0.27+48.04%Beat-88.8%
    Mar 18
    		$0.27$0.33-19.06%Miss-98.6%
    Dec 17
    		$25.73N/AN/ABeat+5988.5%
    Sep 17
    		$17.15N/AN/ABeat+6340.1%
    Jun 17
    		$3.56N/AN/ABeat-
    Mar 17
    		$18.75N/AN/ABeat-
    Dec 16
    		$0.42N/AN/ABeat-
    Sep 16
    		$0.27N/AN/ABeat-

    Dividends

    Dividend Metrics

    Yield0.53%
    Annual/Share$0.06
    Payout Ratio33.46%
    Frequency1
    Pay MonthsJul, Aug

    Growth

    3Y CAGR+5.74%
    5Y CAGR+6.53%
    View RDY's full dividend history

    Key Metrics

    Valuation
    P/E Ratio0.69EV/EBITDA14.54x
    Price/FCF60.32xFCF Yield1.66%
    Profitability
    Profit Margin10.00%Operating Margin4.25%
    ROE8.84%ROIC10.94%
    Financial Health
    Debt/Equity0.15xInterest Coverage14.10x
    Current Ratio1.90xQuick Ratio1.39x
    Trading Statistics
    Beta0.24Avg Volume2.35M
    52-Week High$15.5152-Week Low$11.28

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$12.18
    SMA 20$12.21
    SMA 50$12.77
    SMA 200$13.41
    EMA 10$12.19
    EMA 20$12.22
    EMA 50$12.53
    EMA 200$13.23

    MACD

    Line: -0.09Signal: -0.12Hist: 0.03

    ADX

    ADX: 31.9+DI: 17.9-DI: 29.3

    Aroon & PSAR

    Aroon Up44.0
    Aroon Down40.0
    PSAR$11.83

    Bollinger Bands

    Upper Band$12.43
    Lower Band$11.99
    %B Position362%(Upper)
    Band Width0.30

    RSI (14-Day)

    Neutral
    43.7

    Momentum Oscillators

    Stoch %K38.4
    Stoch %D51.9
    Williams %R-75.0
    ROC (10d)0.1%
    Momentum0.01
    CCI (20d)-52.8
    MFI (14d)51.4

    Volatility Measures

    ATR (14d)$0.23(1.9%)
    StdDev (20d)0.11
    Hist Vol13.6%(Low)

    Volume Flow

    VWAP$12.13
    OBV33.8M
    AD Line-802.2M
    CMF (20d)-0.008

    Volume Metrics

    Avg Vol (20d)2.3M
    Vol Ratio0.9x
    VWMA (20d)$12.21

    Pivot Points

    R3$12.52
    R2$12.42
    R1$12.30
    Pivot Point$12.21
    S1$12.09
    S2$11.99
    S3$11.87

    Advanced Oscillators

    TSI-10.51
    Ultimate Osc49.7
    KST-25.35

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$81.18B$76.33B$87.27B$88.05B$85.45B$85.06B$83.59B$80.16B$76.73B$70.83B$72.15B$832.20M
    Cost of Revenue$43.42B$42.12B$40.46B$39.91B$36.83B$37.80B$34.53B$32.39B$30.38B$29.35B$29.95B$363.25M
    Gross Profit$37.76B$34.22B$46.81B$48.14B$48.63B$47.26B$49.05B$47.77B$46.34B$41.48B$42.20B$468.95M
    Operating Expenses$34.79B$33.74B$32.57B$30.63B$31.15B$29.62B$30.33B$30.22B$28.42B$26.52B$25.30B$293.22M
    R&D$5.80B$5.55B$6.15B$6.20B$6.24B$7.26B$6.66B$7.27B$6.19B$6.88B$5.57B$65.88M
    SG&A$26.10B$14.47B$15.88B$26.44B$23.18B$24.05B$24.12B$23.01B$22.69B$20.48B$20.23B$28.86B
    Operating Income$2.97B$473.25M$14.24B$17.51B$17.48B$17.65B$18.72B$17.55B$17.93B$14.96B$17.27B$175.72M
    Interest Income$999.00M$0$921.00M$912.00M$828.00M$564.00M$704.00M$665.00M$744.00M$647.00M$583.00M$311.00M
    Interest Expense$1.26B$1.07B$951.84M$907.00M$830.00M$656.00M$818.00M$757.00M$598.00M$593.00M$394.00M$353.00M
    Income Before Tax$5.56B$2.02B$15.43B$18.35B$19.05B$20.05B$18.74B$19.17B$18.82B$16.02B$18.26B$231.44M
    Income Tax Expense$1.18B$-217,329,000$3.53B$4.08B$4.95B$4.18B$4.70B$5.75B$4.90B$2.95B$4.47B$52.42M
    Net Income$4.46B$2.24B$12.10B$14.37B$14.18B$15.94B$14.13B$12.55B$13.92B$13.07B$13.79B$179.01M
    EBITDA$2.97B$8.76B$19.56B$24.31B$24.64B$25.26B$24.28B$23.90B$21.76B$20.32B$21.29B$281.03M
    EBITN/A$3.10B$14.51B$19.26B$19.88B$20.71B$19.56B$19.92B$17.95B$16.61B$17.52B$235.20M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about RDY

    News

    Dr Reddy’s arm Aurigene inks global drug manufacturing deal with pharma giant

    Aurigene Pharmaceutical Services Limited, a subsidiary of Dr Reddy’s Laboratories, has secured a long-term manufacturing and supply agreement with a global pharmaceutical company. This deal covers commercial drug-product manufacturing for markets including the US, Europe, and Canada, focusing on sterile injectables, biologics, and topicals. The collaboration is expected to generate revenue starting in 2028, with an anticipated annual production of 18 million units at full commercialization.

    The Times of India•8/25/26•
    Bullish

    Dr. Reddy's Laboratories falls Tuesday, underperforms market

    Shares of Dr. Reddy's Laboratories Ltd. fell 0.29% on Tuesday to 1,191.00 Indian rupees, underperforming the broader market as the BSE SENSEX Index rose 0.37%. The company's stock closed 15.79% below its 52-week high achieved in June.

    MarketWatch•8/25/26•
    Somewhat-Bearish

    Dr. Reddy's Laboratories falls Friday, underperforms competitors

    Dr. Reddy's Laboratories Ltd. shares decreased by 0.54% on Friday, closing at 1,175.00 Indian rupees. This performance lagged behind the overall stock market, as the BSE SENSEX Index remained steady. The company's shares are now 16.93% below their 52-week high reached in June.

    MarketWatch•8/21/26•
    Bearish

    Delhi High Court Cancels 'DAPLOGIN' Trademark Registration Over Similarity With Dr. Reddy's 'DAPLO'

    The Delhi High Court has canceled Razenta Pharmaceuticals' trademark registration for "DAPLOGIN" due to its phonetic similarity with Dr. Reddy's Laboratories' "DAPLO" mark. Both marks are used for Type 2 Diabetes Mellitus medications. The court emphasized the heightened scrutiny required for pharmaceutical trademarks due to potential life-threatening confusion.

    LiveLawBiz•8/20/26•
    Bullish

    Dr. Reddy's Laboratories rallies Thursday, outperforms competitors

    Dr. Reddy's Laboratories Ltd. saw its shares increase by 0.88% on Thursday, closing at 1,181.35 Indian rupees. This performance outpaced the broader market, which also experienced a positive trading session with the BSE SENSEX Index rising 0.82%. Despite the rally, the company's shares were still 16.48% below their 52-week high.

    MarketWatch•8/20/26•
    Bullish

    Frequently Asked Questions About RDY

    What is RDY's current dividend yield?
    Dr. Reddy’s Laboratories Ltd ADR (RDY) has a current dividend yield of 0.53%.
    Does RDY pay dividends?
    Yes, Dr. Reddy’s Laboratories Ltd ADR pays dividends with a current yield of 0.53%.
    What is RDY's P/E ratio?
    Dr. Reddy’s Laboratories Ltd ADR has a price-to-earnings (P/E) ratio of 0.69.
    What is RDY's market cap?
    Dr. Reddy’s Laboratories Ltd ADR (RDY) has a market capitalization of $10.15B with a current stock price of $12.12.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In